Panel Discussion
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
By William H. Carson, MD, Hisashi Kitagawa, PhD, and Charles B. Nemeroff, MD, PhD
Unmet Needs in the Treatment of Anxiety Disorders
By Mark H. Pollack, MD
Late-Life Anxiety Disorders
By Carl Salzman, MD
Understanding Psychiatric Disorders Through Functional Brain Imaging
By Clinton D. Kilts, PhD
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
By Charles B. Nemeroff, MD, PhD